Raymond Woo's most recent trade in Ceribell Inc. was a trade of 51,159 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ceribell Inc. | Raymond Woo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 51,159 | 51,159 | - | - | Stock Option (Right to Buy) | |
| Ceribell Inc. | Raymond Woo | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 30,695 | 148,391 | - | 0 | Common Stock | |
| Oruka Therapeutics Inc. | Raymond Woosley L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| DoubleLine Opportunistic C... | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 5,291 | 0 | - | - | Common Shares | |
| Doubleline Income Solution... | Raymond Woolson B. | Trustee | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 3,659 | 0 | - | - | Common Shares | |
| DoubleLine Yield Opportuni... | B. Raymond Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 1,776 | 0 | - | - | Common Shares | |
| Oruka Therapeutics Inc. | Raymond L. Woosley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2022 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | |
| Westwood Holdings Group Inc | Raymond E. Wooldridge | Director | Purchase of securities on an exchange or from another person at price $ 17.49 per share. | 01 Nov 2021 | 10,000 | 77,597 (0%) | 0% | 17.5 | 174,887 | common stock |
| DoubleLine Yield Opportuni... | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 01 Oct 2021 | 358 | 1,464 | - | - | Common Shares | |
| DoubleLine Yield Opportuni... | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 354 | 1,087 | - | - | Common Shares | |
| Westwood Holdings Group Inc | Raymond E. Wooldridge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 5,609 | 67,597 (0%) | 0% | 0 | common stock | |
| DoubleLine Yield Opportuni... | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 356 | 720 | - | - | Common Shares | |
| Oruka Therapeutics Inc. | Raymond L. Woosley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2021 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| DoubleLine Yield Opportuni... | Raymond B. Woolson | Trustee | Other type of transaction at price $ 0.00 per share. | 04 Jan 2021 | 358 | 358 | - | - | Common Shares | |
| DoubleLine Opportunistic C... | Raymond B. Woolson | TRUSTEE | Other type of transaction at price $ 0.00 per share. | 01 Oct 2020 | 368 | 4,044 | - | - | COMMON SHARES | |
| Westwood Holdings Group Inc | Raymond E. Wooldridge | Director | Purchase of securities on an exchange or from another person at price $ 12.29 per share. | 10 Aug 2020 | 5,000 | 5,000 (0%) | 0% | 12.3 | 61,462 | common stock |
| Westwood Holdings Group Inc | Raymond E. Wooldridge | Director | Purchase of securities on an exchange or from another person at price $ 12.29 per share. | 10 Aug 2020 | 5,000 | 61,988 (0%) | 0% | 12.3 | 61,462 | common stock |